Results 71 to 80 of about 1,547 (116)

Short-Term Intraocular Pressure Trends After Intravitreal Pegcetacoplan Injection

Purpose: To evaluate the short-term intraocular pressure (IOP) response to intravitreal injections (IVI) of 0.1 mL of pegcetacoplan. Methods: A retrospective, cross-sectional study was performed of patients who received IVI of pegcetacoplan for ...
Mazzulla, D. Anthony, Goldblatt, Nathaniel P., Mukhopadhyay, Anirudh   +2 more
core   +1 more source

Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis. [PDF]

Clin J Am Soc Nephrol
Vivarelli M, Ariceta G, Borovitz Y, Borovitz Y, Dixon BP, Greenbaum LA, Greenbaum LA, Licht C, Mastrangelo A, Melhem N, Fujita N, van de Kar NCAJ, Wallace D, Khankin E, Wang Z, López-Lázaro L, Szamosi J, Nester CM.   +17 more
europepmc   +1 more source

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons. [PDF]

Adv Ther
Dixon BP, Bomback AS, Rich C, Hakimi Z, Huang M, Gordon K, Wojciechowski P, Margas W, Chang R, Duh MS, Caravaca-Fontán F, Fakhouri F.   +11 more
europepmc   +1 more source

Complement Inhibition in Geographic Atrophy: Clinical Evidence for Pegcetacoplan and Avacincaptad Pegol. [PDF]

Cureus
Orozco Loaiza G, Alfaro Guerra MJ, Murillo Sotela A, Villalobos Villalobos P.   +3 more
europepmc   +1 more source

Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety. [PDF]

Hemasphere
Griffin M, Fattizzo B, Lee JW, Kelly RJ, Trikha R, Ueda Y, Nishimura JI, Patriquin CJ, Röth A, Muus P, Panse J, Álvarez MG, Pike A, Munir T, Gandhi S, Kulasekararaj A.   +15 more
europepmc   +1 more source

Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review. [PDF]

J Clin Med
Gandhi S, Munro I, Shodimu V, Webb N, Pannagl K, Wiyani A, Balp MM.   +6 more
europepmc   +1 more source

Time-Related Burden of Treatment With Parenterally Administered Complement Inhibitors: A Mixed Methods Observational Study Exploring Experiences among Patients With Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Health Sci Rep
Dingli D, Broderick L, Rizio AA, Rucker S, LaGasse K, Carty MK, Burton E, Gordon S, Yen GP, Paulose J, Geevarghese A, Lee S.   +11 more
europepmc   +1 more source

Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal Hemoglobinuria. [PDF]

Drug Des Devel Ther
Chen C, Zhong J, Xiong D.
europepmc   +1 more source

Transient vitreous opacity following combined intravitreal injection of pegcetacoplan and faricimab-svoa in patients with neovascular age-related macular degeneration and geographic atrophy. [PDF]

Am J Ophthalmol Case Rep
Zhang Y, Wei C, Stewart JM.
europepmc   +1 more source

C3 Glomerulopathy: recent advances and an update on management. [PDF]

J Bras Nefrol
Palma LMP, Barbosa MINH, Sethi S.
europepmc   +1 more source